Trump, Tarrifs and the New FDA Import Inspectors

Environment
Episode Summary:
In this episode of FDA Imports Cross-Border Compliance, regulatory attorney Benjamin L. England breaks down the evolving challenges importers face under shifting U.S. trade policies. With the return of Trump-era tariffs, FDA-regulated companies are encountering unexpected costs, heightened inspection activity, and more frequent supply chain disruptions. Ben shares insights on the growing role of FDA and Customs collaboration, labeling enforcement trends, and strategies importers can use to mitigate risk in an increasingly volatile regulatory environment.

Key Timestamps:
00:01 – Show introduction
02:00 – The return of tariffs and long-term trade implications
05:30 – How FDA-regulated goods are impacted by tariff changes
08:15 – Increased FDA inspections and reallocation of resources
11:10 – Industries most affected: food, cosmetics, medical devices, pharmaceuticals
14:25 – The evolving relationship between FDA and Customs at U.S. ports
18:20 – Common issues triggering shipment holds: labeling, documentation, and new inspector errors
23:05 – Compliance risks when importing from China, India, and Mexico under USMCA
27:40 – Labeling enforcement as a leading cause of FDA detentions
31:10 – Practical steps importers can take to protect shipments and avoid costly delays
34:55 – Key advice for navigating FDA and Customs scrutiny in 2024 and beyond

About the Show:
FDA Imports Cross-Border Compliance is a podcast hosted by attorney Benjamin L. England, founder of FDAImports.com. The show helps importers, exporters, and global businesses navigate the complex legal and regulatory landscape at the U.S. border. With expert insights on FDA, Customs, USDA, DEA, and trade compliance, listeners gain practical strategies to protect their products and keep supply chains moving.

#FDAImports #TradeCompliance #Tariffs #USMCA #ImportLaw